Pharmidex attending the 2022 Joint Meeting (DMDG-GMP-SPS)
October 1, 2022
Pharmidex are proud to be sponsoring the 2022 DMDG joint meeting
03 October 2022 - 05 October 2022
A meeting run jointly by the Drug Metabolism Discussion Group (DMDG, UK), Group of Metabolism and Pharmacokinetics (GMP, France) and the Swedish Academy of Pharmaceutical Sciences (SPS, Sweden.
👉 www.pharmidex.com/medical-device-testing-services With over 23 years of experience in preclinical R&D, we’re expanding our capabilities to support the development and regulatory testing of innovative medical devices from biocompatibility assessments to in vitro and in vivo efficacy models. This new service allows us to collaborate even more closely with biotech companies, CRO partners, academic innovators and medical device startups helping bring safe, effective and transformative technologies to patients faster. Whether you're exploring a novel implant, delivery system, or diagnostic platform, our team is ready to support you at every step with the same scientific integrity and agility that Pharmidex is known for. 💡 Let’s accelerate innovation, together.
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
Martin Barrett , Head of Business Development, will attend the symposium on 10–13 June 2025 at Hotel Comwell Borupgaard, Denmark. The event gathers top European scientists to discuss drug discovery. Martin looks forward to connecting with academia, CROs, and pharma to explore collaborations and showcase Pharmidex’s services from in silico to in vivo pharmacology. Attending? Let’s connect! 🔗 https://lnkd.in/ev7TW7WG
